Sanofi (SNY) reported Q1 earnings Thursday of 1.79 euros ($2.04) per share, up from 1.53 euros a year earlier.
Revenue for the quarter ended March 31 was 9.90 billion euros, compared with 8.93 billion euros a year earlier.
Analysts polled by FactSet expected 9.95 billion euros.
The company reaffirmed its 2025 business EPS guidance of a low double-digit percentage growth at current exchange rate. It also maintained sales guidance to grow by a mid-to-high single-digit percentage at current exchange rate. Analysts polled by FactSet expect 44.97 billion euros.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。